STT3A/B Inhibitors

N/A

Report date: 2025/04/14 16:57:34
NME

Base Information

Drug NameSTT3A/B Inhibitors
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionDolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A inhibitorsDolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B inhibitors
TargetsDolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3ADolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellzome GmbhVir Biotechnology IncGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesCellzome GmbhGlaxosmithkline PlcVir Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A